DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Evaluation of the Efficacy and Safety of Nise 100 mg in the Management of Osteoarthrosis (Gonarthrosis)

Phase 4
Completed
Conditions
Knee Osteoarthritis
Interventions
Drug: NISE
First Posted Date
2016-10-04
Last Posted Date
2016-10-04
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
202
Registration Number
NCT02922712

Amtolmetin Gaucil in Knee Osteoarthritis

Completed
Conditions
Knee Osteoarthritis
Interventions
Drug: NISELAT
First Posted Date
2016-08-12
Last Posted Date
2016-09-30
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
220
Registration Number
NCT02865161

A Study to Assess the Efficacy, Safety and Tolerability of DFD-04

Phase 2
Completed
Conditions
Rosacea
Interventions
Drug: DFD-04 Ointment
Other: Placebo Ointment
First Posted Date
2016-07-11
Last Posted Date
2019-01-23
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
61
Registration Number
NCT02828241
Locations
🇩🇪

Site 201, Berlin, Germany

🇩🇪

Site 208, Berlin, Germany

🇩🇪

Site 202, Bochum, Germany

and more 5 locations

Levofloxacin in Bacterial Rhinosinussitis

First Posted Date
2016-03-18
Last Posted Date
2016-03-18
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
100
Registration Number
NCT02712502

Non Interventional Study of Levofloxacin in Chronic Prostatitis

Completed
Conditions
Chronic Prostatitis
First Posted Date
2016-03-17
Last Posted Date
2016-03-17
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
500
Registration Number
NCT02711943

Ketorol Gel in Gonarthrosis and Low Back Pain

First Posted Date
2015-12-23
Last Posted Date
2017-03-13
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
240
Registration Number
NCT02638831

Pilot Study of DFN-11 Injection in Medication Overuse Headache

Phase 2
Terminated
Conditions
Medication Overuse Headache
Interventions
Drug: DFN-11 Injection
First Posted Date
2015-10-22
Last Posted Date
2018-04-03
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
27
Registration Number
NCT02583425
Locations
🇺🇸

Clinvest, Springfield, Missouri, United States

A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies

Phase 3
Completed
Conditions
Scabies
Interventions
Drug: Permethrin
First Posted Date
2015-10-09
Last Posted Date
2016-10-14
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
250
Registration Number
NCT02572986
Locations
🇺🇸

Sun Research Institute, San Antonio, Texas, United States

🇺🇸

Zain Research, LLC, Richland, Washington, United States

🇺🇸

Derm Dx Center for Dermatology, Hazleton, Pennsylvania, United States

and more 10 locations

Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating Migraine

Phase 2
Completed
Conditions
Rapidly Escalating Migraine
Interventions
Drug: DFN-11
First Posted Date
2015-10-08
Last Posted Date
2019-02-26
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
24
Registration Number
NCT02571049
Locations
🇺🇸

Clinvest, Springfield, Missouri, United States

DFN-11 Injection in Episodic Migraine With or Without Aura

Phase 3
Completed
Conditions
Episodic Migraine
Interventions
Other: Placebo
Drug: DFN-11
First Posted Date
2015-10-07
Last Posted Date
2018-07-26
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
268
Registration Number
NCT02569853
Locations
🇺🇸

Dr. Reddy's Investigational Site #26, Greensboro, North Carolina, United States

🇺🇸

Dr. Reddy's Investigational Site #25, Memphis, Tennessee, United States

🇺🇸

Dr. Reddy's Investigational Site #27, Boise, Idaho, United States

and more 13 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy